Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by INVSTIGAT0Ron Apr 10, 2019 9:27am

108 Views

Post# 29606054

RE:RE:RE:RE:RE:Should You Buy Aphria Inc. Stock Ahead of Earnings?

A billion next year is pretty attainable. 400+ million from CC Pharma and we'll only need to sell about half our capacity to add an extra 600 million in Canada alone. Some revenues from LATAM and possibly Germany will start trickling in as well so it's a soild goal. $40+ target is reasonable by end of fiscal 2020 especially if we start heading into decent profits.

Bullboard Posts

Unique Battery Metals opportunity in Quebec